60.99 percent of total value of consideration paid or received (in case of investment disposal to the extent that a subsidiary or affiliate no longer viable) based on the audited financial statement as at
n.a. Finance cost (290.7) (200.8) 44.7% (281.2) 3.4% Share of profit/loss from JVs/associates (equity income) (430.4) 284.1 n.a. (238.4) (80.5%) Reported Net Profit/(Loss) (1,213.1) 390.3 n.a. (806.6
(51.5%) Operating expenses (716.5) (581.5) 23.2% (937.8) (23.6%) Selling and administrative expenses1 (743.8) (700.0) 6.3% (1,054.8) (29.5%) EBITDA 33.1 131.6 (74.9%) 2,116.5 (98.4%) Finance cost (281.2
60.99 percent of total value of consideration paid or received (in case of investment disposal to the extent that a subsidiary or affiliate no longer viable) based on the audited financial statement as at
higher selling price and higher sale volume in CNF incoterm, while lower unit sold and appreciation of Thai baht against US dollar. . Cost of goods sold and expenses Three-month (Thousands Baht) Change
cost over the long term, which will in turn help reduce costs within the economic system.. Within this context, KBank and K Companies accentuate enhancement of our business capabilities to achieve
increased 63.10 percent due to higher gain from exchange rate. 1.2 Cost of goods sold and expenses Consolidated (Thousands Baht) Year Change 4th Quarter Change 2018 2017 Amount % 2018 2017 Amount % Cost of
incomes increased 0.22 million baht. Total increased 1.26 million baht. Cost of sales for the three months ended March 31, 2017 amounted to 31.76 million baht. (2016: amounting to 29.19 million baht) The
incomes decreased 0.47 million baht. Total decreased 5.78 million baht. Cost of sales for the three months ended March 31, 2019 amounted to 30.00 million baht. (2018: amounting to 28.26 million baht) The
. amount Baht 3.09 million. The other income went down 18.48% amount to Baht 5.00 million. 2. The cost of medical treatments when compared to income from medical treatments decreased 2.56% due to the cost of